Lupin, Amman Pharma join hands to launch ophthalmic drug in West Asian market
Lupin and Amman Pharma have inked a licensing and supply agreement for the biosimilar Ranibizumab
Lupin and Amman Pharma have inked a licensing and supply agreement for the biosimilar Ranibizumab